Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY)

CAPS Rating: 1 out of 5

A development stage company focuses on the discovery and development of oncolytic viruses for the treatment of cancers.

Recs

0
Player Avatar pchop123 (79.42) Submitted: 1/3/2013 1:00:15 PM : Underperform Start Price: $4.00 ONCY Score: +5.80

likely to fall way down again after this short term rise

Featured Broker Partners


Advertisement